SCHEMBL6023217

SCHEMBL6023217

CC(C)(C)c1cc(C(=O)C=CN2CCN(c3ccc(N)cc3)CC2)cc(C(C)(C)C)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 2/20 0.48
GFER P55789 3/20 0.42
CASP6 P55212 1/20 0.42
MAPT P10636 7/20 0.40
ALDH1A1 P00352 6/20 0.40
GAA P10253 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ADRA2C P18825 1/20 0.40
PTK2B Q14289 1/20 0.40
ESR2 Q92731 1/20 0.40
ALOX12 P18054 4/20 0.39
LMNA P02545 3/20 0.39
MEN1 O00255 2/20 0.37
MAOB P27338 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022926 0.85 CTSL (0.47) TNFRSF1AMAPTALDH1A1GAAKMT2A
SCHEMBL4319308 0.80 ALDH1A1 (0.54) GFERCASP6MAPTALDH1A1GAA
SCHEMBL6023052 0.78 MAPT (0.40) GFERCASP6MAPTALDH1A1GAA
SCHEMBL6022867 0.77 MAPT (0.39) GFERCASP6MAPTALDH1A1GAA
SCHEMBL6023475 0.77 MAPT (0.41) GFERCASP6MAPTALDH1A1GAA
SCHEMBL4379029 0.75 TNFRSF1A (0.48) TNFRSF1AMAPTALDH1A1GAAKMT2A
SCHEMBL6023953 0.75 THRB (0.40) GFERCASP6MAPTALDH1A1KMT2A
SCHEMBL6023219 0.75 ME2 (0.52) GFERCASP6MAPTALDH1A1GAA
SCHEMBL4320476 0.71 ALDH1A1 (0.63) GFERMAPTALDH1A1GAAKMT2A
SCHEMBL3150983 0.69 MAPT (0.43) TNFRSF1AGFERMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 TNFRSF1A 4536/4885GFER 3119/4885CASP6 2316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.